mesothelin

A2 Bio Reports First CAR-T Complete Response in Lung Cancer

CHICAGO, Illinois, 21 May 2026 A2 Biotherapeutics, Inc. announced new safety and efficacy results from its ongoing EVEREST-2 Phase...

By cGxPwire Editor
May 23, 2026

Bio-Pharma

Verismo Therapeutics Unveils Promising CAR T Advances for Solid Tumors at SITC 2025

Philadelphia, November 10, 2025 — Verismo Therapeutics, a clinical-stage biotechnology company pioneering KIR-CAR T cell therapies, presented compelling preclinical...

By cGxPwire Editor
November 11, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

mesothelin

A2 Bio Reports First CAR-T Complete Response in Lung Cancer

Verismo Therapeutics Unveils Promising CAR T Advances for Solid Tumors at SITC 2025